Organ and Functional Preservation in the Management of Genitourinary Cancer: Bladder, Prostate, and Penis

References

• American Cancer Society. Cancer Facts and Figures, 1993. Atlanta, GA 1993
   Google Scholar
• Hannisdal Fossu E. S., Host D. H. Blood tests and prognosis in bladder carcinomas treated with definitive radiotherapy. Radiother Oncol 1993; 27: 117–122
   PubMed Web of Science ®Google Scholar
• Parsons J T. Conservative treatment of muscle invasive bladder cancer using radiotherapy. Front Radiat Oncol 1993; 27: 143–165
   PubMedGoogle Scholar
• Shipley W U, Prout G RJR, Kaufman D S. Bladder cancer—Advances in laboratory innovations and clinical management. with emphasis on innovatons allowing bladder sparing approaches for patients with invasive tumors. Cancer 1990; 65: 695–683
   Google Scholar
• Gospodarowicz M, Rider K. WD., Keen C W. Bladder cancer: Long term follow-up results of patients treated with radical radiation. Clin Oncol 1991; 3: 155–161
   PubMedGoogle Scholar
• Smaaland R, Akslen L A, Jonder B. Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients. Br J Urol 1991; 67: 61–69
   PubMedGoogle Scholar
• Salminen E. External beam radiation treatment of urinary bladder carcinoma. Acta Oncol 1990; 29: 909–914
   PubMed Web of Science ®Google Scholar
• Johnson S, Pedersen J, Westman G. bladder carcinoma: A 20 year review of radical irradiation therapy. Radiother Oncol 1991; 22: 111–117
   PubMed Web of Science ®Google Scholar
• Duncan W, Quilty P M. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 1986; 7: 299–310
   PubMed Web of Science ®Google Scholar
• Goffinet D R, Schneider M J, Glatstein E J. Bladder cancer: Results of radiation therapy in 384 patients. Radiology 1975; 117: 149–153
   PubMed Web of Science ®Google Scholar
• Miller L S, Johnson D E. Megavoltage irradiation for bladder cancer: Arone, postoperative, or preoperative. Genitour Cancer 1973; 10: 771–782
   Google Scholar
• Hope-Stone H F, Blandy J P, Oliver R TD. Radical radiotherapy and salvage cystectomy in the treatment of invasive carcinoma of the bladder. Bladder Cancer: Principles of Combination Therapy, RTD Oliver, WF Hendry, HJG Bloom. Butterworths, London 1981; 177–188
   Google Scholar
• Van der Werft Messing B HP, Menin R S, Hop W CJ. Cancer of the urinary bladder category T2T3 (NXM0) treated by interstitial radium implant: second report. Int J Radiat Oncol Biol Phys 1983; 9: 481–485
   PubMed Web of Science ®Google Scholar
• Mazeron J J, Crook J, Chopin D. Conservative treatment of bladder carcinoma by partial cystectomy and interstitial iridium-192. Int J Radiat Oncol Biol Phys 1988; 15: 1323–1330
   PubMed Web of Science ®Google Scholar
• Rozan R, Albiusson E, Donnarieix D. Interstitial iridium-192 for bladder cancer (a multicentric survey: 205 patients). Int J Radiat Oncol Biol Phys 1992; 24: 469–477
   PubMed Web of Science ®Google Scholar
• Edsmyr F, Anderson L, Esposti P L. Irradiation therapy with multiple small fractions per day in urinary bladder cancer. Radiother Oncol 1985; 4: 197–203
   PubMed Web of Science ®Google Scholar
• Maciejewski B, Majewski S. Dose fractionation and tumor repopulation in radiotherapy for bladder cancer. Radiother Oncol 1991; 21: 163–170
   PubMed Web of Science ®Google Scholar
• Horwich A. Prognosis of bladder cancer. Radiother Oncol 1992; 24: S65, Suppl
   Google Scholar
• Mousa L., El-Moreim S A, Eid N. Accelerated hyperfractionated radiotherapy and concomitant chemotherapy with radiotherapy in locally advanced cancer of the bilharzial bladder. Radiother Oncol 1992; 24: S82, Suppl
   Google Scholar
• Awwad H K, Abd El Moneim H, Abd El Baki H. The topical use of misonidazole in bladder cancer. Prog Clin Biol Res 1983; 132D: 305
   PubMedGoogle Scholar
• Abratt R P, Barnes D R, Pontin A R. Radical radiation and oral and intravesical misonidazole for bladder cancer. Int J Radiat Oncol Biol Phys 1987; 13: 1053
   PubMed Web of Science ®Google Scholar
• Abratt R P, Crainghead P, Reddi V B. A prospective randomized trial of radiation with or without oral and intravesical misonidazole for bladder cancer. Br J Cancer 1991; 64: 968–970
   PubMed Web of Science ®Google Scholar
• Shipley W U, Prout G R, Einstein A B. Treatment of invasive bladder cancer by cis-platinum and radiation in patients unsuited for surgery. JAMA 1981; 258: 931–935
   Google Scholar
• Porter A T, Tester W, Pilepich M. Preliminary results of the RTOG protocol 8512 evaluating a study of the use of combination modality therapy with organ preservation in moderate invasive carcinoma of the bladder. Int J Radiat Oncol Biol Phys 1988; 15: 212–213, (Suppl 1)
   Google Scholar
• Russell K, Higono C, Boileau M. Combined 5-fluorouracil and irradiation for the treatment of invasive bladder cancer. Int J Radiat Oncol Biol Phys 1989; 17: 1029–1036, (Suppl)
   Google Scholar
• Rotman M, Macchia R, Silverstein M. Treatment of advanced carcinoma with irradiation and concomitant 5FU infusion. Cancer 1989; 59: 710–714
   Web of Science ®Google Scholar
• Mori Y, Ihara H, Shinea K. Combined cis-platinum and radiation therapy in patients with invasive bladder cancer. Int Urol Nephrol 1990; 22: 337–344
   PubMedGoogle Scholar
• Sauer R, Dunst J, Altendor F, Hoffman A. Radiotherapy with and without cis-platinum in bladder cancer. Int J Radiat Oncol Biol Phys 1990; 19: 681–691
   Google Scholar
• Chauvet B, Brewer Y, Felix-Faure C. Combined radiation therapy and cis-platinum for locally advanced carcinoma of the urinary bladder. Cancer 1993; 72: 2213–2218
   PubMed Web of Science ®Google Scholar
• Prout G R, Shipley W U, Kaufman D S. Interval report of a phase I–II study utilizing multiple modalities in the treatment of invasive bladder cancer—A bladder sparing study. Urol Clin North Am 1991; 18: 547–554
   PubMed Web of Science ®Google Scholar
• Stemberg C N, Arena M G, Calabresi F. Neoadjuvant M-VAC for infiltrating transitional cell carcinoma of the bladder. Cancer 1993; 72: 1975–1982
   PubMed Web of Science ®Google Scholar
• Marino R, Wajsman Z. Bladder sparing approach to muscle invasive carcinoma of the bladder. Prog Clin Biol Res 1990; 353: 175–178
   PubMedGoogle Scholar
• Paz-Ares L, Lianes P., Diaz-Puente M. CMV front line chemotherapy in transitional bladder carcinoma. AM Oncol 1993; 4: 147–150
   Google Scholar
• Kuten A, Baz M, Rubinov R. Treatment of invasive bladder cancer—Is there a role for neoadjuvant chemotherapy. Eur J Cancer 1993; 29A: S 229, (Suppl 6)
   Google Scholar
• Kaufman D S, Shipley W U, Griffin P P. Selective bladder preservation by combination treatment of invasive bladder cancer. N Engl J Med 1993; 329(19)1377–1382
   PubMed Web of Science ®Google Scholar
• Mettlin C, Jones G W, Murphy G P. Trends in prostate cancer care in the United States, 1974–1990: Observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer J Clin 1993; 43(2)83–91
   PubMed Web of Science ®Google Scholar
• Babaian R J, Camps J L, Frangos D N. Monoclonal prostate-specific antigen in untreated prostate cancer: Relationship to clinical stage and grade. Cancer 1991; 67: 2200–2206
   PubMed Web of Science ®Google Scholar
• Killian C S, Yang N, Emrich L J. Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer. Cancer Res 1985; 4: 886–991
   Google Scholar
• Zagars G K, Von Eschenbach A C. Prostate-specific antigen, an important marker for prostate cancer treated by external beam radiation therapy. Cancer 1993; 72(2)538–548
   PubMed Web of Science ®Google Scholar
• Jewett H J. The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am 1975; 2(1)105–124
   PubMedGoogle Scholar
• Leandri P, Rossignol G, Gautier J R. Radical retropubic prostatectomy: Morbidity and quality of life. Experience with 620 consecutive cases. J Urol 1992; 147(3)883–887
   PubMed Web of Science ®Google Scholar
• Walsh P C. Radical retropubic prostatectomy with reduced morbidity: An anatomic approach. NCI Monogr 1988; 7: 133–137
   PubMedGoogle Scholar
• Byar D P, Mostofi F. Carcinoma of the prostate. Prognostic evaluation of certain pathologic features in 208 radical prostatectomies examined by the step-section technique. Cancer 1972; 30(1)5–13
   PubMed Web of Science ®Google Scholar
• Catalona W J, Stein A J. Accuracy of frozen section detective of lymph nodes metastasis in prostatic carcinoma. J Urol 1982; 127(3)460–461
   PubMed Web of Science ®Google Scholar
• Gibbons R P, Correa RJ, Jr, Brannen C E. Total prostatectomy for localized prostate cancer. J Urol 1984; 13(1)73–76
   Google Scholar
• Paulson D F, Lin G H, Hinshaw W. Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol 1982; 128(3)502–504
   PubMed Web of Science ®Google Scholar
• Paulson D F. Randomized series of treatment with surgery versus radiation for prostate adenocarcinoma. NCI Monogr 1988; 7: 127–13I
   PubMedGoogle Scholar
• Consensus statement. The management of clinically localized prostate cancer. NCI Monogr 1988; 7: 3–6
   PubMedGoogle Scholar
• Zagars G K, Von Eschenbach A C, Ayah A G. Prognostic factors in prostate cancer. Cancer 1993; 72(5)1709–1725
   PubMed Web of Science ®Google Scholar
• Bagshaw M A, Kaplan I D, Cox R C. Radiation therapy for localized disease. Cancer 1992; 71(3)939–952, Suppl
   Web of Science ®Google Scholar
• Paulson D F, Moul J W, Walther P J. Radical prostatectomy for clinical stage TI-2NOM0 prostate adenocarcinoma: Long term results. J Urol 1990; 144(5)1180–1184
   PubMed Web of Science ®Google Scholar
• Epstein J I, Pizov G, Walsh P C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993; 71: 3582–3593
   PubMed Web of Science ®Google Scholar
• Morgan W R, Bergstralh E J, Zincke H. Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer. Urology 1993; 41: 113–120
   PubMed Web of Science ®Google Scholar
• Walsh P C, Jewett H J. Radical surgery for prostatic cancer. Cancer 1980; 45(7)1906–1911
   PubMed Web of Science ®Google Scholar
• Walsh P C, Lepor H., Eggelston J C. Radical prostatectony with preservation of sexual function: Anatomical and pathological consideration. Prostate 1983; 4(5)473–485
   PubMed Web of Science ®Google Scholar
• Catalona W J. Patient selection for, results of. and impact in tumor resection of potency sparing radical prostatectomy. Urol Clin North Am 1990; 17(4)819–826
   PubMed Web of Science ®Google Scholar
• Shipley W U, Prout GR, Jr, Coachman N M. Radiation therapy for localized prostate carcinoma: Experience at the Massachusetts General Hospital (1973–1981). NCI Monogr 1988; 7: 67–73
   PubMedGoogle Scholar
• Morton J D, Peschel R E. Iodine-125 implants versus external beam therapy for stage A2, B and prostate cancer. Int J Radiat Oncol Biol Phys 1985; 14(6)1153–1157
   Google Scholar
• Kuban D A, El-Mahdi A M, Schellhammer P F. 1–125 interstitial implantation for prostate cancer. What have we learned 10 years later. Cancer 1989; 63(12)2415–2420
   PubMed Web of Science ®Google Scholar
• Syed A M, Puthawala A, Austin P. Temporary iridium-192 implant in the management of carcinoma of the prostate. Cancer 1992; 69(10)2515–2524
   PubMed Web of Science ®Google Scholar
• Brindle J S, Martinez A, Schray M. Pelvic lymphadenectomy and transperineal interstitial implantation of IR 192 combined with external beam radiotherapy for bulky stage C prostatic carcinoma. Int J Radiat Oncol Biol Phys 1989; 17(5)1063–1066
   PubMed Web of Science ®Google Scholar
• Epstein B E. Low complication rate with conformal radiotherapy for cancer of the prostate. Radiother Oncol 1992; 24: 5100, (suppl abstract)
   Google Scholar
• Sandler H M, Perez-Tamayo C, Ten Haken R K. Dose escalation for stage C (T3) prostate cancer: Minimal rectal toxicity observed using conformal therapy. Radiother Oncol 1992; 23(1)53–54
   PubMed Web of Science ®Google Scholar
• Epstein B E, Hanks G E. Radiation therapy techniques and dose selection in the treatment of prostate cancer. Semin Radiat Oncol 1993; 3: 179–186
   PubMedGoogle Scholar
• Griffin T W, Russell K J, Peters L J. Fast neutron irradiation of locally advanced prostate cancer. Semin Oncol 1988; 15: 359–365
   PubMed Web of Science ®Google Scholar
• Perez C A, Pilepich M V, Garcia D. Definition radiation therapy in carcinoma of the prostate localized to the pelvis: Experience at the Mallinckrodt Institute of Radiology. NCI Monogr 1988; 7: 85–94
   PubMedGoogle Scholar
• Pilepich MV., Perez C A, Walz B J. Complications of definitive radiotherapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1981; 7: 1341–1348
   PubMed Web of Science ®Google Scholar
• Quinlan D M, Epstein J I, Carter B S. Sexual function following radical prostatectomy: Influences of preservation of neurovascular bundles. J Urol 1990; 145(5)998–1002
   Web of Science ®Google Scholar
• Zinreich E S, Derogatis L, Herpst R. J. Pre and post treatment evaluation of sexual function in patients with adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1990; 19(3)729–732
   PubMed Web of Science ®Google Scholar
• Crawford E D, Dawkins C A. Cancer of the penis. Diagnosis and Management of Genitourinary Cancer, DG Skinner, G Lieskovsky. WB Saunders, Philadelphia 1988; 549–563
   Google Scholar
• Barrasso R, DeBrux J, Croissant O, Orth G. High prevalence of papillomavisuo-associated penile intraepitheal neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med 1987; 317(15)916–923
   PubMedGoogle Scholar
• Sufrin G, Huben R. Benign and malignant lesions of the penis. Adult and Pediatric Urology, JY Gillenwater, JT Grahack, SS Howards, JW Ducket. Year Book, Chicago 1987; 1448–1462
   Google Scholar
• Mohs F E, Snow S N, Messing M E, Kuglitsch M D. Microscopically controlled surgery in the treatment of carcinoma of the penis. JUrol 1985; 133: 971–966
   Google Scholar
• Salaverria J C, Hope-Stone H F, Pams A M. Conservative treatment of carcinoma of the penis. Br J Urol 1979; 5(1)32–37
   Google Scholar
• Kelley E D, Artheru K, Rogoff E. Radiation therapy of penile cancer. Urology 1974; 4: 571
   PubMedGoogle Scholar
• Knoll L D, Segura J W, Benson R C, Goellner J R. Bowenoid papulosis of the penis: Successful management with neodymium: YAG laser. J Urol 1988; 139: 1307–1309
   PubMed Web of Science ®Google Scholar
• Jackson S M. The treatment of carcinoma of the penis. Br J Surg 1966; 53: 33–35
   PubMed Web of Science ®Google Scholar
• Beahrs O H, Henson D E, Hutter R V, Kennedy B J. Handbook of Staging of Cancer. AJCC & TNM Commission of the IUCC
   Google Scholar
• Fraley E, Zhang E. G., Sazama R, Lange P H. Cancer of the penis: Progress and treatment plans. Cancer 1985; 55: 1618–3624
   PubMed Web of Science ®Google Scholar
• Parkash S, Anathakrishnan N, Roy P. Refashioning of phallus stumps and phalloplasty in the treatment of carcinoma of the penis. Br J Surg 1986; 73: 902–905
   PubMed Web of Science ®Google Scholar
• McDougal W, Kirchner S. FK., Edwards R H, Killian L T. Treatment of carcinoma of the penis: The case for primary lymphadec-tomy. J Urol 1986; 136: 3841
   Google Scholar
• Fraley E E, Zhang G, Manivel C., Niehans G A. Role of ilioinguinal lymphadenectomy and significance of histological differentiation in treatment of carcinoma of the penis. J Urol 1989; 142: 1478–1483
   PubMed Web of Science ®Google Scholar
• Young M J, Reda D J, Waters W B. Penile carcinoma: A twenty-five-year experience. J Urol 1991; 38: 529–532
   Google Scholar
• Persky L, DeKernion J. Carcinoma of the penis. Ca Cancer J Clin 1986; 36: 258–273
   PubMed Web of Science ®Google Scholar
• Wajsman Z, Moore R H, Merrin C E. Surgical treatment of penile cancer. Cancer 1977; 40: 1697–1701
   PubMed Web of Science ®Google Scholar
• Pierquin B, Chassagne D, Chahbazian Wilson C. J. Brachytherapy. Warren H Green, St Louis 1978; 193–196
   Google Scholar
• Mazeron J J, Langlois D, Lobo P A, Huart J A. Interstitial radiation therapy for carcinoma of the penis using Indium 192 wires. Int J Radiat Oncol Biol Phys 1984; 10: 1891
   PubMed Web of Science ®Google Scholar
• Delannes M, Melavaud B, Douchez J. Iridium 192 interstitial therapy for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 1992; 24: 479–483
   PubMed Web of Science ®Google Scholar
• Franzen L, Henriksson R, Karlsson N O. A technical device for irradiation in carcinoma of the penis. Acta Oncol 1987; 26: 77–78
   PubMed Web of Science ®Google Scholar
• Sagerman R H, Yu W S, Chung C T, Puranik A. External beam irradiation of carcinoma of the penis. Radiology 1984; 152: 183
   PubMed Web of Science ®Google Scholar
• Duncan W, Jackson S M. The treatment of early cancer of the penis with megavoltage X-rays. Clin Radiol 1972; 23(2)246–248
   PubMedGoogle Scholar
• Gerbaulet A, Lambin P. Radiation therapy of cancer of the penis. Indications, advantages and pitfalls. Urol Clin North Am 1992; 19: 325–332
   PubMed Web of Science ®Google Scholar
• Gagliano R C, Blumenstein B A, Crawford E D. Cis-diaminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: A Southwest Oncology Group Study. J Urol 1989; 141: 66–67
   PubMed Web of Science ®Google Scholar
• Ahmed T, Sklaroff R, Yagoda A. Sequential trials of methotrex-ate, cisplatin and bleomycin for penile cancer. J Urol 1984; 132(3)465–468
   PubMed Web of Science ®Google Scholar